Examining von Willebrand Disease Treatment and the Role of Specialty Pharmacy Services

Date:               Wednesday, May 1, 2019

Location:         Wynn and Encore Hotels
3131 S Las Vegas Boulevard
Las Vegas, Nevada 89109

Room: Beethoven

Time:               7:00 am – 8:30 am
                        *Breakfast will be available

Program Description
Von Willebrand disease (VWD) is the most common bleeding disorder, affecting up to 1% of the population worldwide, and is caused by the absence of, reduced amounts of, or defects in von Willebrand factor (VWF). Human plasma-derived VWF concentrates containing varying amounts of VWF multimer distribution and factor VIII (FVIII) content have been available for decades. A recombinant VWF eliminates the need for human donors, decreases the risk for any infectious transfers, and minimizes the thrombosis risk due to the absence of FVIII. Specialty pharmacists should know how to tailor these therapies for specific patients’ needs. Effective interventions will maximize quality of life, reduce hospitalizations and emergency department visits, optimize health care utilization, and effectively manage bleeding risk and adverse events during disease management.

Educational Objectives
  • Determine the classifications of VWD and their impact on patient care
  • Analyze the data of FDA-approved VWD factors and identify their role in therapy
  • Examine practices for managing the cost and availability of VWD treatments    

Faculty Presenters

Tim Affeldt, PharmD
Director of Specialty/Infusion Operations
Fairview Pharmacy Services
Minneapolis, Minnesota

Sheh-Li Chen, PharmD
Clinical Pharmacy Specialist in Benign Hematology
University of North Carolina Medical Center
Chapel Hill, North Carolina

This activity is supported by an educational grant from Grifols.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-19-043-L01-P. The activity is available for CE credit for May 1, 2019.

Obtaining Credit:
All participants who attended the live symposium need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Detailed instructions on obtaining credit will be provided at the session. Credit must be requested no later than July 1, 2019.